Cases 1 - 8 of 8
Classen Immunotherapies, Inc. v. Shionogi, Inc. et al
as 1:2013cv00921
Plaintiff:
Classen Immunotherapies, Inc.
Defendant:
Shionogi, Inc. and Merz Pharmaceuticals, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Classen Immunotherapies Inc v. Somaxon Pharmaceuticals
as 2:2012cv06643
Plaintiff:
Classen Immunotherapies Inc
Defendant:
Somaxon Pharmaceuticals
CLASSEN IMMUNOTHERAPIES, INC. v. KAPPOS
as 1:2010cv01232
Plaintiff:
CLASSEN IMMUNOTHERAPIES, INC.
Defendant:
DAVID KAPPOS
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Classen Immunotherapies, Inc. v. Biogen Idec
as 06-1634
Defendant:
THE PERMANENTE FEDERATION, LLC, KAISER PERMANENTE INSURANCE COMPANY, KAISER FOUNDATION ADDED CHOICE HEALTH PLAN, INC. and others
Amicus Curiae:
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Defendant / Cross Appellant:
MERCK & CO., INC.
Plaintiff / Appellant:
CLASSEN IMMUNOTHERAPIES, INC.
Defendant / Appellee:
BIOGEN IDEC and GLAXOSMITHKLINE
CLASSEN IMMUNO V BIOGEN IDEC
as 06-1634
Defendant-Appellee:
Biogen Idec Inc. and GlaxoSmithKline
Biogen Idec Inc:
Plaintiff-Appellant:
Classen Immunotherapies, Inc.
Defendant/Cross Appellant:
Merck & Co., Inc.
CLASSEN IMMUNO V KING PHARMA
as 06-1219
Plaintiff/Counterclaim Defendant-Appellant:
Classen Immunotherapies, Inc., Classen Immunotherapies, Inc. and Classen Immunotherapies, Inc.
Defendant/Counterclaimant-Appellee:
Elan Pharmaceuticals, Inc., Elan Pharmaceuticals, Inc. and Elan Pharmaceuticals, Inc.
Defendant-Appellee:
King Pharmaceuticals, Inc., King Pharmaceuticals, Inc. and King Pharmaceuticals, Inc.
CLASSEN IMMUNO V BIOGEN IDEC
as 06-1216
Defendant/Counterclaimant-Appellee:
BIOGEN IDEC, GALAXOSMITHKLINE, BIOGEN IDEC and others
Plaintiff/Counterclaim Defendant-Appellant:
CLASSEN IMMUNOTHERAPIES, INC., CLASSEN IMMUNOTHERAPIES, INC. and CLASSEN IMMUNOTHERAPIES, INC.
Defendant-Appellee:
KAISER FOUNDATION HEALTH PLAN, INC., KAISER FOUNDATION HEALTH PLAN, INC. and KAISER FOUNDATION HEALTH PLAN, INC.
Classen Immunotherapies, Inc. v. GalaxoSmithKline et al
as 1:2004cv02607
Plaintiff:
Classen Immunotherapies, Inc.
Defendant:
Biogen Idec, GalaxoSmithKline, Chiron Corporation and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
